Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Lilly reports compounds for postmenopausal syndrome

April 15, 1997

Pharmacia & Upjohn introduces new GH delivery device

April 14, 1997

Orally active GH secretagogues reported by Lilly

April 14, 1997

Lilly granted rights to gene/protein involved in islet neogenesis

April 11, 1997

Canadian approval for Depo-Provera

April 10, 1997

Amgen obtains additional EPO patent protection

April 10, 1997

Roussel Uclaf transfers all rights and responsibilities related to mifepristone to Dr. Sakiz

April 10, 1997

GelTex issued U.S. patent for cholesterol-reducing polymers

April 10, 1997

Ergoset enters clinical trials as adjunct therapy for type II diabetes

April 10, 1997

Lilly describes agents for postmenopausal syndrome

April 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026